Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...
In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...
DICER1 encodes an RNase III endoribonuclease critical for the biogenesis of microRNAs, small regulatory RNAs that fine-tune gene expression. Germline loss-of-function mutations in DICER1 underlie an ...
Germ cell tumors (GCTs) are a heterogeneous group of neoplasms that predominantly affect adolescents and young adults. Notably, geographical disparities in GCT incidence exist, with higher rates ...
Patients with cancer who have germline mutations overwhelmingly acknowledge the importance of informing relatives of their risks, but gaps in testing show the health care system has not adequately ...
A Stanford Medicine study of thousands of breast cancers has found that inherited gene sequences may be powerful predictors of the breast cancer type that might develop decades later, and how deadly ...
The cost of convenience: Evaluating economic differences in SQ and IV biotherapeutic formulations. Overall – Total Cost per FDR ($1,000s USD) Tested – Total Cost per FDR ($1,000s USD) Untested – Total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results